Cure My Disease

Don't miss your cure!

 Log in / Sign up

Laser microscope may speed up skin cancer diagnosis

NCT ID NCT06598137

Diagnosis Sponsor: LMU Klinikum Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 26, 2026 · Last updated Aug 27, 2026 · Updated 1 time

Summary

This trial is testing whether a special laser microscope can quickly and accurately examine skin lesions, including benign tumors, basal cell carcinoma, melanoma, and squamous cell cancer. The goal is to see if this technique can determine the extent, structure, and type of a skin change without sending tissue samples for lengthy lab analysis. About 645 patients with benign or malignant skin tumors will take part.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Ex vivo confocal laser scanning microscopy
What this could lead to
If successful, this could enable faster, more accurate skin cancer diagnosis and margin control without lengthy lab processing.
What could go wrong
The technique may not match traditional lab accuracy, and results depend on the skill of the operator and the type of lesion.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 645 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2024

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with benign and malignant skin tumors

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with benign and malignant skin tumors Exclusion Criteria: * Patients unable to consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Basal cell carcinoma are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

basal cell carcinoma benign neoplasm of skin melanoma squamous cell carcinoma squamous cell neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Basal cell carcinoma Benign skin tumor Melanoma Squamous cell cancer

Contacts and locations

Locations

  • Clinic for Dermatology and Allergy LMU Munich

    Munich, Bavaria, 80337, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.